193 related articles for article (PubMed ID: 12618884)
21. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells.
He YF; Tian DY; Yi ZJ; Yin ZK; Luo CL; Tang W; Wu XH
Asian J Androl; 2012 Sep; 14(5):788-92. PubMed ID: 22902906
[TBL] [Abstract][Full Text] [Related]
23. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
24. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
25. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC
Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
[TBL] [Abstract][Full Text] [Related]
26. p63 in laryngeal squamous cell carcinoma: evidence for a role of TA-p63 down-regulation in tumorigenesis and lack of prognostic implications of p63 immunoreactivity.
Pruneri G; Pignataro L; Manzotti M; Carboni N; Ronchetti D; Neri A; Cesana BM; Viale G
Lab Invest; 2002 Oct; 82(10):1327-34. PubMed ID: 12379767
[TBL] [Abstract][Full Text] [Related]
27. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
[TBL] [Abstract][Full Text] [Related]
28. Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
Papadogianni D; Soulitzis N; Delakas D; Spandidos DA
Tumour Biol; 2014 Mar; 35(3):2481-9. PubMed ID: 24213852
[TBL] [Abstract][Full Text] [Related]
29. p63 gene expression study and early bladder carcinogenesis.
Compérat E; Bièche I; Dargère D; Ferlicot S; Laurendeau I; Benoît G; Vieillefond A; Verret C; Vidaud M; Capron F; Bedossa P; Paradis V
Urology; 2007 Sep; 70(3):459-62. PubMed ID: 17905096
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases.
Compérat E; Camparo P; Haus R; Chartier-Kastler E; Bart S; Delcourt A; Houlgatte A; François R; Capron F; Vieillefond A
Virchows Arch; 2006 Mar; 448(3):319-24. PubMed ID: 16283378
[TBL] [Abstract][Full Text] [Related]
31. Pattern of p63 expression in squamous cell carcinoma of the oral cavity.
Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Gatto MR; Frezza GP; Pession A
Virchows Arch; 2004 Apr; 444(4):332-9. PubMed ID: 14997391
[TBL] [Abstract][Full Text] [Related]
32. Expression of p63 protein and mRNA in oral epithelial dysplasia.
Chen YK; Hsue SS; Lin LM
J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
[TBL] [Abstract][Full Text] [Related]
33. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization and expression of p63 isoforms in human keloids.
De Felice B; Wilson RR; Nacca M; Ciarmiello LF; Pinelli C
Mol Genet Genomics; 2004 Aug; 272(1):28-34. PubMed ID: 15248062
[TBL] [Abstract][Full Text] [Related]
35. Expression of the p53 family of proteins in central and peripheral human corneal endothelial cells.
Paull AC; Whikehart DR
Mol Vis; 2005 May; 11():328-34. PubMed ID: 15889017
[TBL] [Abstract][Full Text] [Related]
36. Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients.
Stefansson IM; Salvesen HB; Akslen LA
Int J Cancer; 2006 Mar; 118(5):1227-33. PubMed ID: 16152605
[TBL] [Abstract][Full Text] [Related]
37. Aberrant expression of beta-catenin and mutation of exon 3 of the beta-catenin gene in renal and urothelial carcinomas.
Zhu X; Kanai Y; Saito A; Kondo Y; Hirohashi S
Pathol Int; 2000 Dec; 50(12):945-52. PubMed ID: 11123760
[TBL] [Abstract][Full Text] [Related]
38. Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium.
Lin C; Yin Y; Stemler K; Humphrey P; Kibel AS; Mysorekar IU; Ma L
Cancer Res; 2013 Oct; 73(19):5914-25. PubMed ID: 23928991
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin involved in inactivation of WNT/beta-catenin signalling in urothelial carcinoma and normal urothelial cells.
Thievessen I; Seifert HH; Swiatkowski S; Florl AR; Schulz WA
Br J Cancer; 2003 Jun; 88(12):1932-8. PubMed ID: 12799639
[TBL] [Abstract][Full Text] [Related]
40. Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas.
Tai G; Ranjzad P; Marriage F; Rehman S; Denley H; Dixon J; Mitchell K; Day PJ; Woolf AS
PLoS One; 2013; 8(11):e81167. PubMed ID: 24260555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]